vendredi 10 mars 2017

Onco Actu du 10 mars 2017

1. Biologie

ICREA: promoting latest discovery to better elucidate cancer evolution and tumor heterogeneity [VHIO]

Targeting cancer cell suicide: a TRAIL of two faces [Cancer Research UK]

Ways of escape [The Darwin Cancer Blog]

3.8 Prévention - Alimentation

Here’s how to write better headlines on diet studies [HealthNewsReview]

4.7 Dép., diag. & prono. - Col de l'utérus

Five myths about the new cervical screening program that refuse to die [The Conversation]

5. Traitements

Novel compound that engages 'second arm' of immune system reduces breast tumors and metastases, study shows [Dana-Farber Cancer Institute]

5.10 Traitements - Essais

Cancer experts urge reform of paediatric cancer trial rules [PharmaTimes]

5.12.2 Immunothérapies - CAR-T

Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis [EndPoints]

5.2 Pharma

EU nod for Actelion’s rare immune system cancer drug [PharmaTimes]

As biosimilars hit, EU pharma warns against blanket prescribing [Reuters]

5.2.3 Pharma - économie

Cancer specialist BeyondSpring lands on the Nasdaq with a $54M IPO [FierceBiotech]

6.1 Observation

Latest monthly figures show worst performance for cancer waiting times target in England on record [Cance Research UK]

Pregnancy around time of breast cancer diagnosis not a risk to mom: study [Globe and Mail]

6.10 Politiques

At 10, Europe’s ‘excellence’ fund faces calls for change [Science]

6.10.1 Politiques (USA)

Tanning Industry, Taxed Under Obama, Cheers G.O.P. Health Bill [NY Times]

6.11 Patients

Veteran French crooner Johnny Hallyday admits to having cancer but denies it is life-threatening [The Telegraph]

6.9 Controverses

DePinho resigns as MD Anderson president, acknowledges shortcomings as administrator [The Cancer Letter]